The association between admission hyperglycaemia and the no-reflow phenomenon in STEMI patients undergoing primary percutaneous coronary intervention

Abstract

No-reflow phenomenon is not uncommon in acute myocardial infarction patients treated by primary percutaneous coronary intervention (PPCI). It is associated with poorer left ventricular systolic dysfunction and higher mortality in such patients.1 Diabetes was linked to increased incidence of no-reflow in PPCI.2 We hypothesised that acute admission hyperglycemia, rather than diabetes, is responsible for this complication. We prospectively studied 120 consecutive ST-elevation myocardial infarction …